FDA Approvals Propel Cellular Gene Therapy Forward
The FDA has approved over 40 cellular and gene therapy products, marking significant progress in the field. Recent approvals include treatments for rare genetic disorders and advancements in CAR T-cell therapy for cancer. The regulatory landscape is evolving to facilitate faster access to these therapies, which aim to provide curative solutions rather than just symptom management. The focus is on precision medicine, targeting the root causes of diseases with advanced genetic tools. 
